Actavis acquires Forest for $25bn Ramps up its shift into specialty pharmaceuticals Actavis has announced its largest acquisition to date, confirming a $25bn takeover of Forest Laboratories. Once finalized the generic drug company will gain blockbuster franchises in CNS, gastroenterology, women’s health, urology and cardiovascular, and combined annual revenues expected to top $15bn next year. […]
US to expedite imports for some drugmakers under new supply chain plan By Zachary Brennan, 19-Feb-2014 The US FDA announced on Monday that it would initiate a Secure Supply Chain Pilot Program to enhance the security of imported drugs. Full Article: http://www.in-pharmatechnologist.com/Regulatory-Safety/US-to-expedite-imports-for-some-drugmakers-under-new-supply-chain-plan
NCPA: U.S. Reps. contact Medicare in support of proposed changes for 2015 drug plans February 12, 2014 | By Michael Johnsen ALEXANDRIA, Va. — Members of Congress are contacting the U.S. Centers for Medicare and Medicaid Services in support of pro-patient improvements the agency proposed for Medicare Part D prescription drug plans in 2015, a […]
GAO: Federal upper limits 1.4% lower than National Average Drug Acquisition Cost February 7, 2014 | By Michael Johnsen WASHINGTON — In a report publicly released Thursday by the U.S. Government Accountability Office, the GAO found that the total draft federal upper limits amount based on the new formula under the Patient Protection and Affordable […]
Trxade Health, Inc. (NASDAQ: MEDS)